All the news Showing 6 of 6 articles from: Kidney disease & HCVGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Higher kidney disease risk persists in people cured of hepatitis C Keith Alcorn / 19 July 2022 People with hepatitis C remain at higher risk of chronic kidney disease after clearing or being cured of hepatitis C and people with genotype 1 infection have a higher risk of kidney ... The incidence of diabetes, stroke and kidney disease falls after hepatitis C cure Keith Alcorn / 12 November 2018 The incidence of some of the most serious extrahepatic health problems caused by hepatitis C declines sharply after the infection is cured by antiviral treatment, a review of people treated for hepatitis ... HCV therapy with SVR reduces the risk of several non-liver-related diseases commonly seen in people with chronic HCV Michael Carter / 06 July 2017 The risk of several non-liver complications associated with chronic hepatitis C virus (HCV) infection is reduced after interferon-based treatment that achieves a sustained virological response (SVR), investigators from the United ... Curing hepatitis C reduces the risk of diabetes & kidney failure in people with HIV/HCV co-infection Keith Alcorn / 01 February 2017 Curing hepatitis C infection substantially reduces the risk of developing type 2 diabetes in people with HIV/hepatitis C virus (HCV) co-infection, but does not reduce the risk of cardiovascular disease, ... Glecaprevir/pibrentasvir effective for people with hepatitis C and severe kidney disease Liz Highleyman / 22 December 2016 A two-drug pangenotypic regimen combining AbbVie's glecaprevir and pibrentasvir demonstrated a high sustained response rate for people with chronic hepatitis C who have severe kidney impairment, according to results from the EXPEDITION-4 study ... Curing hepatitis C may help reduce kidney disease progression Liz Highleyman / 20 December 2016 People who achieved sustained virological response to interferon-based hepatitis C treatment experienced significantly less decline in kidney function, especially if they had liver cirrhosis, according to study findings presented at the 2016 AASLD ... ← First1Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive